Literature DB >> 13329944

Extractable insulin of the pancreas and effectiveness of oral hypoglycaemic sulfonylureas in the treatment of diabetes in man; a comparison.

G A WRENSHALL, C H BEST.   

Abstract

Entities:  

Keywords:  DIABETES MELLITUS/pathology; INSULIN; SULFONAMIDES/therapeutic use; UREA/derivatives

Mesh:

Substances:

Year:  1956        PMID: 13329944      PMCID: PMC1824450     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  12 in total

1.  Correlation of beta-cell granulation with extractable insulin of the pancreas; studies in adult human diabetics and nondiabetics.

Authors:  W S HARTROFT; G A WRENSHALL
Journal:  Diabetes       Date:  1955 Jan-Feb       Impact factor: 9.461

2.  Insulin extractable from the pancreas and islet cell histology; comparative studies in spontaneous diabetes in dogs and human subjects.

Authors:  G A WRENSHALL; W S HARTROFT; C H BEST
Journal:  Diabetes       Date:  1954 Nov-Dec       Impact factor: 9.461

3.  Hypoglycemic action of sulfonylureas in patients with diabetes mellitus.

Authors:  I A MIRSKY; D DIENGOTT; H DOLGER
Journal:  Science       Date:  1956-04-06       Impact factor: 47.728

4.  Insulin-sparing sulfonamides.

Authors:  L W KINSELL; F R BROWN; G D FRISKEY; G D MICHAELS
Journal:  Science       Date:  1956-04-06       Impact factor: 47.728

5.  [A new anti-diabetes principle; results of clinical research].

Authors:  H FRANKE; J FUCHS
Journal:  Dtsch Med Wochenschr       Date:  1955-10-07       Impact factor: 0.628

6.  [An effective peroral anti-diabetic drug (BZ 55)].

Authors:  F BERTRAM; E BENDFELDT; H OTTO
Journal:  Dtsch Med Wochenschr       Date:  1955-10-07       Impact factor: 0.628

7.  [A new blood-sugar reducing substance; preliminary data].

Authors:  J D ACHELIS; K HARDEBECK
Journal:  Dtsch Med Wochenschr       Date:  1955-10-07       Impact factor: 0.628

8.  Hypoglycemic effects of 1-butyl-3-p-toluene sulfonylurea given orally in human diabetic subjects; a preliminary report.

Authors:  M MILLER; J W CRAIG
Journal:  Metabolism       Date:  1956-03       Impact factor: 8.694

9.  The inhibition of insulinase by hypoglycemic sulfonamides.

Authors:  I A MIRSKY; G PERISUTTI; D DIENGOTT
Journal:  Metabolism       Date:  1956-03       Impact factor: 8.694

10.  Extractable insulin of pancreas; correlation with pathological and clinical findings in diabetic and nondiabetic cases.

Authors:  G A WRENSHALL; A BOGOCH; R C RITCHIE
Journal:  Diabetes       Date:  1952 Mar-Apr       Impact factor: 9.461

View more
  9 in total

1.  [EFFECT OF OBESITY ON THE INSULIN ACTIVITY AND PHYSIOLOGIC INSULIN RESERVE IN DIABETES ACQUIRED IN MATURE LIFE].

Authors:  H DAWEKE; W WINKELMANN; I BACH
Journal:  Klin Wochenschr       Date:  1965-02-15

2.  Mode of action and side-effects of phenformin hydrochloride.

Authors:  R S WALKER; A L LINTON; W S THOMSON
Journal:  Br Med J       Date:  1960-11-26

3.  Experience with glipasol (R. P. 2259)-an antidiabetic sulfonamide drug.

Authors:  T W DAVIS; R B KERR; A BOGOCH
Journal:  Can Med Assoc J       Date:  1959-07-15       Impact factor: 8.262

4.  Oral hypoglycaemic drugs.

Authors:  J D SLATER
Journal:  Postgrad Med J       Date:  1959-05       Impact factor: 2.401

5.  [On the determination of insulin in the blood of epididymal fatty tissue of the rat with the aid of marked glucose. II. Experimental and clinical experiences].

Authors:  E F PFEIFFER; M PFEIFFER; H DITSCHUNEIT; C S AHN
Journal:  Klin Wochenschr       Date:  1959-12-01

6.  Oral treatment of diabetes with tolbutamide.

Authors:  I SINGH
Journal:  Br Med J       Date:  1957-12-07

7.  The hypoglycaemic sulphonylureas.

Authors:  G WALKER
Journal:  Postgrad Med J       Date:  1957-05       Impact factor: 2.401

8.  Clinical experience with tolbutamide.

Authors:  G WALKER; J D SLATER; E K WESTLAKE; J D NABARRO
Journal:  Br Med J       Date:  1957-08-10

9.  Carbutamide in juvenile diabetes.

Authors:  J M SMELLIE
Journal:  Br Med J       Date:  1958-03-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.